Exclusion Criteria:~Absence of a reliable caregiver. Clinical or radiological evidence for other neurological
disorders such as Parkinson's disease, normal pressure hydrocephalus, multi-infarct dementia, idiopathic
seizure disorder, CNS infectious disease.~History of major psychiatric disorders; schizophrenia and unipolar or
bipolar depression.~Presence of any significant medical disorder which might cause or contribute to dementia
such as B12 or folic acid deficiency, untreated hypothyroidism, history of significant alcohol abuse (within
the past 10 years).~Patients with recent (< 2 years) hematologic/oncologic disorders (other than basal or
squamous cell carcinoma of the skin.~Patients with recent (< 3 months) myocardial infarction, poorly controlled
CHF, surgery for peripheral vascular disease, or coronary artery bypass surgery.~Evidence of clinically
significant or unstable active GI, hepatic or pulmonary disease.~History of documented stroke or more than one
confirmed TIA. Any condition which would make the patient or caregiver, in the opinion of the principal
investigator unsuitable for the study.~Patients with known hypersensitivity to Donezepil HCL or other
piperidine containing drugs.
